Lexington Biosciences, Inc. Stock Canadian Securities Exchange
Equities
LNB
CA5290204067
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +6.67% | +166.67% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 36.58 50.4 |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 664 914.73 | Net cash position 2022 * | - 0 | EV / Sales 2022 | - |
P/E ratio 2021 |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 13.79% |
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 20-04-15 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Tamara Manuel
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-3.72% | 186B | |
-2.60% | 107B | |
-3.79% | 67.44B | |
+2.66% | 50.03B | |
+16.39% | 47.81B | |
+4.91% | 41.03B | |
+1.38% | 26.85B | |
+1.52% | 25.82B | |
-1.17% | 25.01B |
- Stock Market
- Equities
- LXGT.F Stock
- LNB Stock